Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Saptausaha Gemilangindah Tbk. (SAGE) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Saptausaha Gemilangindah Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Saptausaha Gemilangindah Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 319B, 1.7K 24h volume), while Saptausaha Gemilangindah Tbk. trades at Rp32 (market cap 257.07B). The key difference: Diagnos Laboratorium Utama Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.

DGNSSAGE
Market Cap
319B257.07B
Volume
1.7K
Lot
17
Turnover
392K
Average Price
230.59
Value
392K
Indicative Equilibrium Price
23232
Indicative Equilibrium Volume
2001.18K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
SAGE
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Saptausaha Gemilangindah Tbk.

PT Saptausaha Gemilangindah Tbk (the Company) was established on July 29, 1992 based onNotarial Deed No. 63 of Sulaimansjah, S.H., notary in Jakarta. The Company started its commercial operations on 2017.

Read more on SAGE